Literature DB >> 20042398

Intrarenal vascular resistance parameters in kidney transplant patients receiving calcineurin inhibitor-based or sirolimus-based regimens.

Po-Chu Lee1, Chih-Yuan Lee, Rey-Heng Hu, Chiao Lo, Meng-Kun Tsai, Po-Huang Lee.   

Abstract

BACKGROUND: Use of a calcineurin inhibitor (CNI) immunosuppressant following kidney transplantation is associated with development of vasomotor nephrotoxicity. This study was undertaken to evaluate and compare the influences of CNI-based and CNI-free immunosuppressant regimens on two intrarenal vascular resistance parameters, the resistive index (RI) and the pulsatility index (PI), in renal transplant recipients.
METHODS: Forty-nine renal transplant patients who received ultrasonography examination between January 2007 and December 2007 were enrolled in this case-control study. Thirty-one subjects received a CNI-based regimen, and 18 received a CNI-free (sirolimus-based) regimen. RI and PI were determined by duplex Doppler ultrasonography.
RESULTS: Patients receiving a CNI displayed lower cholesterol and triglyceride values and higher RI (mean: 0.7 vs. 0.6, P = 0.002) and PI values (mean: 1.3 vs. 1.1, P = 0.034). Multivariate analyses revealed that advanced age and use of alpha-blockers or diuretics were modestly associated with higher RI and PI values. By multivariate analysis, use of sirolimus was associated with a lower RI by -0.05 [95% confidence interval (CI): -0.085, -0.019; P = 0.003] but not with a lower PI (95% CI: -0.245, 0.001; P = 0.053).
CONCLUSIONS: Use of sirolimus is only modestly correlated with a reduced RI and is not associated with a reduced PI. These observations question the superiority of CNI-free over CNI-based regimens with regard to reduction of intrarenal vascular resistance post-transplantation. These findings combined with those regarding recipient factors also cast doubt on the specificity of intrarenal resistance indices for predicting allograft function and/or survival.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20042398     DOI: 10.1093/ndt/gfp716

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  3 in total

1.  Sirolimus conversion efficacy for graft function improvement and histopathology in renal recipients with mild to moderate renal insufficiency.

Authors:  Dong Jin Joo; Chul Woo Yang; Hyeon Joo Jeong; Beom Jin Lim; Kyu Ha Huh; Byung Ha Chung; Yeong Jin Choi; Shin-Wook Kang; Yu Seun Kim
Journal:  J Korean Med Sci       Date:  2014-07-30       Impact factor: 2.153

2.  Shear wave elastography and Doppler ultrasound in kidney transplant recipients.

Authors:  Luana Marinho Gonçalves; Gabriele Carra Forte; Tiago Garcia Holz; Lucas Lobraico Libermann; Carlos Eduardo Poli de Figueiredo; Bruno Hochhegger
Journal:  Radiol Bras       Date:  2022 Jan-Feb

3.  The Effect of Maintenance Treatment with Twice-Daily or Prolonged Once-Daily Tacrolimus Formulation on Visual Evoked Potentials in Stable Kidney Transplant Recipients.

Authors:  Aureliusz Kolonko; Małgorzata Jurys; Sebastian Sirek; Tomasz Dwulit; Dorota Pojda-Wilczek; Andrzej Więcek
Journal:  J Clin Med       Date:  2020-06-11       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.